139 related articles for article (PubMed ID: 30973467)
1. Pancreatic Ductal Adenocarcinoma Derived From an Intraductal Papillary Neoplasm With Synchronous Incidental Glucagonoma: A Case Report and Literature Review.
Cornacchia C; Rutigliani M; Serventi A; Ciferri E; Angelini G; Filauro M
Pancreas; 2019 Apr; 48(4):e24-e26. PubMed ID: 30973467
[No Abstract] [Full Text] [Related]
2. Favorable response after gemcitabine-radiotherapy for invasive pancreatic intraductal papillary mucinous neoplasm: a case report.
Ochiai T; Igari K; Furuyama T; Ito H; Mitsunori Y; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
Int Surg; 2013; 98(4):340-5. PubMed ID: 24229021
[TBL] [Abstract][Full Text] [Related]
3. S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Kozuki A; Tokumaru T; Iiyama T; Kosaki T; Kobayashi M; Hanazaki K
World J Surg; 2014 Nov; 38(11):2986-93. PubMed ID: 25104544
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Invasive Ductal Carcinoma in the Fat Replacement of the Pancreatic Body and Tail].
Ebihara T; Yamamoto T; Hoshino H; Yoshimura J; Sasamatsu S; Hiraki Y; Nishi H; Shimizu K; Kawada M; Inoue T; Kato F; Amano K; Mikami J; Yamamura J; Makari Y; Nakata K; Ikeda N; Kamigaki S; Tsujie M; Kimura Y; Nakata Y; Munakata S; Ohzato H
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2354-6. PubMed ID: 26805362
[TBL] [Abstract][Full Text] [Related]
5. Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma.
Toll AD; Dasgupta A; Potoczek M; Yeo CJ; Kleer CG; Brody JR; Witkiewicz AK
Hum Pathol; 2010 Sep; 41(9):1205-9. PubMed ID: 20573371
[TBL] [Abstract][Full Text] [Related]
6. Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials.
Kurreck A; Weckwerth J; Modest DP; Striefler JK; Bahra M; Bischoff S; Pelzer U; Oettle H; Kruger S; Riess H; Sinn M
Eur J Cancer; 2021 Jun; 150():250-259. PubMed ID: 33940349
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expression.
Kobayashi M; Mizuno S; Murata Y; Kishiwada M; Usui M; Sakurai H; Tabata M; Ii N; Yamakado K; Inoue H; Shiraishi T; Yamada T; Isaji S
Pancreas; 2014 Apr; 43(3):350-60. PubMed ID: 24622063
[TBL] [Abstract][Full Text] [Related]
8. Acinar cell carcinoma--a rare tumour of the pancreas.
Klipin M; Sparaco A; Omoshoro-Jones J; Smith MD
S Afr J Surg; 2008 Aug; 46(3):88. PubMed ID: 18807305
[No Abstract] [Full Text] [Related]
9. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Seufferlein T; Bachet JB; Van Cutsem E; Rougier P;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii33-40. PubMed ID: 22997452
[No Abstract] [Full Text] [Related]
10. Dorsal pancreas agenesis and ductal adenocarcinoma: surgical implications of an extremely rare association.
Dumitraşcu T; Scarlat A; Diaconescu A; Ionescu M
Chirurgia (Bucur); 2012; 107(3):389-92. PubMed ID: 22844839
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.
Miyazawa M; Katsuda M; Maguchi H; Katanuma A; Ishii H; Ozaka M; Yamao K; Imaoka H; Kawai M; Hirono S; Okada KI; Yamaue H
Int J Cancer; 2017 Feb; 140(4):973-982. PubMed ID: 27861852
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of pre-operative chemoradiotherapy with gemcitabine to treat pancreatic cancer in patients with impaired renal function.
Tomimaru Y; Eguchi H; Satoh T; Tomokuni A; Asaoka T; Wada H; Marubashi S; Ogawa K; Takehara T; Mori M; Doki Y; Nagano H
Jpn J Clin Oncol; 2015 Apr; 45(4):343-8. PubMed ID: 25589454
[TBL] [Abstract][Full Text] [Related]
13. [Palliative treatment of pancreatic cancer].
Seufferlein T; von Wichert G; Adler G
Dtsch Med Wochenschr; 2007 Apr; 132(15):813-7. PubMed ID: 17427092
[No Abstract] [Full Text] [Related]
14. An indeterminate mucin-producing cystic neoplasm containing an undifferentiated carcinoma with osteoclast-like giant cells: a case report of a rare association of pancreatic tumors.
Chiarelli M; Guttadauro A; Gerosa M; Marando A; Gabrielli F; De Simone M; Cioffi U
BMC Gastroenterol; 2015 Nov; 15():161. PubMed ID: 26581412
[TBL] [Abstract][Full Text] [Related]
15. One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.
Brown DB; Gonsalves CF; Yeo CJ; Witkiewicz AK; Carr BI
Oncol Rep; 2010 Sep; 24(3):767-9. PubMed ID: 20664985
[TBL] [Abstract][Full Text] [Related]
16. Non-secreting benign glucagonoma diagnosed incidentally in a patient with refractory thrombocytopenic thrombotic purpura: report of a case.
Georgiou GK; Gizas I; Katopodis KP; Katsios CS
Surg Today; 2015 Oct; 45(10):1317-20. PubMed ID: 25373364
[TBL] [Abstract][Full Text] [Related]
17. Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection.
Schneitler S; Kröpil P; Riemer J; Antoch G; Knoefel WT; Häussinger D; Graf D
World J Gastroenterol; 2015 May; 21(20):6384-90. PubMed ID: 26034375
[TBL] [Abstract][Full Text] [Related]
18. Downsizing to resectability of a large solid and cystic papillary tumor of the pancreas by single-agent chemotherapy.
Kanter J; Wilson DB; Strasberg S
J Pediatr Surg; 2009 Oct; 44(10):e23-5. PubMed ID: 19853735
[TBL] [Abstract][Full Text] [Related]
19. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs in pancreatic cancer.
Ducreux M; Boige V; Malka D
Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
